Public Health and Legislative Strategies in Tobacco Control: Evaluating Vaping, Nicotine Dependence, and Secondhand Exposure
Abstract
Tobacco control remains a critical public health priority, requiring a balance between regulatory policies, harm reduction strategies, and public awareness campaigns to mitigate nicotine dependence and associated health risks.While traditional cigarette smoking rates have declined, the rise of electronic nicotine delivery systems (ENDS), including vaping, has introduced new challenges for policymakers and healthcare professionals.Proponents argue that vaping serves as a harm reduction tool for smokers transitioning away from combustible tobacco, while opponents cite concerns over youth initiation, long-term health effects, and nicotine addiction.The effectiveness of tobacco control policies, including taxation, advertising restrictions, smoking bans, and flavor prohibitions, remains central to reducing smoking prevalence and preventing secondhand smoke and aerosol exposure.Legislative strategies such as the Framework Convention on Tobacco Control (FCTC), minimum legal sales age regulations, and restrictions on nicotine concentration levels play a crucial role in shaping the accessibility and use of tobacco and vaping products.However, enforcement disparities, industry influence, and loopholes in regulation hinder comprehensive control efforts.Additionally, secondhand exposure to both traditional tobacco smoke and e-cigarette aerosols poses ongoing public health concerns, particularly for vulnerable populations such as children and non-smoking adults.This paper evaluates…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.